The global transradial access market size was estimated to be USD 2.36 billion in 2023 and is expected to reach at USD 5.29 billion by 2034 with a CAGR of 7.62% during the forecast period 2024-2034. Rising preference for interventional procedures using radial artery access, increasing prevalence of cardiovascular diseases such as peripheral artery disease (PAD), surge in use of radial access devices in pediatric patients, growing geriatric population, rising number of patients suffering from heart rhythm disorders, increasing research & development activities, growing technological developments, and surge in approval of advanced transradial access devices by regulatory authorities are some of the key factors boosting the market growth.
Surge in approval of advanced transradial access devices by regulatory authorities is predicted to boost the market growth during the forecast period. The transradial access technique is employed for diagnosing coronary artery disease, encompassing procedures like diagnostic angiography, angioplasty, and percutaneous stenting. The transradial access kit comprises various smaller components, including sheaths, catheters, guidewires, sheath introducers, and accessories. This procedure is capable of identifying blockages in a person's heart artery who is experiencing the symptoms and pain associated with the disease. Hence, market players are focusing on development of advanced devices. For instance, in February 2023, Abbott has unveiled two regulatory approvals as part of its expanding range of electrophysiology products in the worldwide market. The company's TactiFlex Ablation Catheter, Sensor Enabled, which is the sole ablation catheter globally featuring a flexible tip and contact force sensing, has received CE Mark1 clearance. This approval is for the treatment of individuals with irregular heart rhythms, such as atrial fibrillation (AFib). In addition, in May 2023, Abbott has disclosed that the U.S. Food and Drug Administration (FDA) has granted approval for the company's TactiFlex Ablation Catheter, Sensor Enable, making it the world's inaugural ablation catheter equipped with both a flexible tip and contact force technology.
By product, catheter was the highest revenue-grossing segment in the global transradial access market in 2023 owing to the increasing prevalence of cardiovascular diseases such as atherosclerosis, cardiomyopathy, congenital heart disease, heart failure, & heart valve disease, growing public awareness regarding disease management, surge in number of interventional & angiography procedures, and rising launch of advanced devices. For instance, in January 2023, Bentley, a worldwide leader in endovascular treatment for aortic and peripheral vascular conditions, has introduced the BeBack Crossing Catheter, specifically developed for addressing highly calcified lesions. This release marks a significant milestone in Bentley's early history, complemented by the acquisition of the GoBack catheter. Additionally, sheaths & sheath introducers is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of heart disorders & cancer, rising technological advancements, and surge in introduction of innovative devices.
By application, drug administration was the highest revenue-grossing segment in the global transradial access market in 2023 owing to the increasing usage of radial access devices for drug administration for the treatment of infections & cancer disorders and surge in technological advancements. Additionally, diagnostics & testing is predicted to grow at fastest CAGR during the forecast period owing to the rising demand for early diagnosis of the diseases, increasing number of diagnostic procedures performed, and growing introduction of advanced devices. For instance, in November 2022, Merit Medical Systems, Inc., a prominent global provider and promoter of healthcare technology, has unveiled the commercial availability of the PreludeSYNC EZ Radial Compression Device in the United States.
By end-user, hospitals & clinics was the highest revenue-grossing segment in the global transradial access market in 2023 owing to the surge in number of transradial procedures performed in hospital settings, growing number of highly qualified healthcare professionals, increasing demand for continuous patient monitoring, and rising approvals by regulatory bodies. For instance, in September 2022, Penumbra Inc. has reported that its RED Reperfusion Catheters have obtained CE Mark approval and are currently accessible for commercial use in Europe. These catheters are integral components of the Penumbra device, a fully connected mechanical aspiration thrombectomy system designed to reestablish blood flow in individuals experiencing Acute Ischemic Stroke (AIS). Additionally, ambulatory care centers is predicted to grow at fastest CAGR during the forecast period owing to its cost-effectiveness, productivity, increasing healthcare infrastructure, and surge in adoption of cutting-edge technologies.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing research & development activities, increasing prevalence of CVDs, rising number of clinical trial procedures for vascular access devices, and surge in launch of new products. For instance, in February 2023, Ra Medical Systems, Inc. has made an announcement regarding its wholly-owned subsidiary, Catheter Precision, Inc., which has initiated the launch of its LockeT product in the market. Initial shipments to distributors will commence promptly. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing geriatric population, rising prevalence of heart disorders, growing technological advancements, and surge in use of radial access devices. For instance, in April 2023, Surmodics, Inc., a prominent supplier of medical device and in vitro diagnostic technologies to the healthcare sector, has revealed that Dr. Ankur Lodha in Lafayette, Louisiana, and Dr. Pradeep Nair in Houma, Louisiana, are the inaugural physicians to employ the company's Sublime radial access microcatheter.
Surge in approval of advanced transradial access devices by regulatory authorities is predicted to boost the market growth during the forecast period. The transradial access technique is employed for diagnosing coronary artery disease, encompassing procedures like diagnostic angiography, angioplasty, and percutaneous stenting. The transradial access kit comprises various smaller components, including sheaths, catheters, guidewires, sheath introducers, and accessories. This procedure is capable of identifying blockages in a person's heart artery who is experiencing the symptoms and pain associated with the disease. Hence, market players are focusing on development of advanced devices. For instance, in February 2023, Abbott has unveiled two regulatory approvals as part of its expanding range of electrophysiology products in the worldwide market. The company's TactiFlex Ablation Catheter, Sensor Enabled, which is the sole ablation catheter globally featuring a flexible tip and contact force sensing, has received CE Mark1 clearance. This approval is for the treatment of individuals with irregular heart rhythms, such as atrial fibrillation (AFib). In addition, in May 2023, Abbott has disclosed that the U.S. Food and Drug Administration (FDA) has granted approval for the company's TactiFlex Ablation Catheter, Sensor Enable, making it the world's inaugural ablation catheter equipped with both a flexible tip and contact force technology.
By product, catheter was the highest revenue-grossing segment in the global transradial access market in 2023 owing to the increasing prevalence of cardiovascular diseases such as atherosclerosis, cardiomyopathy, congenital heart disease, heart failure, & heart valve disease, growing public awareness regarding disease management, surge in number of interventional & angiography procedures, and rising launch of advanced devices. For instance, in January 2023, Bentley, a worldwide leader in endovascular treatment for aortic and peripheral vascular conditions, has introduced the BeBack Crossing Catheter, specifically developed for addressing highly calcified lesions. This release marks a significant milestone in Bentley's early history, complemented by the acquisition of the GoBack catheter. Additionally, sheaths & sheath introducers is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of heart disorders & cancer, rising technological advancements, and surge in introduction of innovative devices.
By application, drug administration was the highest revenue-grossing segment in the global transradial access market in 2023 owing to the increasing usage of radial access devices for drug administration for the treatment of infections & cancer disorders and surge in technological advancements. Additionally, diagnostics & testing is predicted to grow at fastest CAGR during the forecast period owing to the rising demand for early diagnosis of the diseases, increasing number of diagnostic procedures performed, and growing introduction of advanced devices. For instance, in November 2022, Merit Medical Systems, Inc., a prominent global provider and promoter of healthcare technology, has unveiled the commercial availability of the PreludeSYNC EZ Radial Compression Device in the United States.
By end-user, hospitals & clinics was the highest revenue-grossing segment in the global transradial access market in 2023 owing to the surge in number of transradial procedures performed in hospital settings, growing number of highly qualified healthcare professionals, increasing demand for continuous patient monitoring, and rising approvals by regulatory bodies. For instance, in September 2022, Penumbra Inc. has reported that its RED Reperfusion Catheters have obtained CE Mark approval and are currently accessible for commercial use in Europe. These catheters are integral components of the Penumbra device, a fully connected mechanical aspiration thrombectomy system designed to reestablish blood flow in individuals experiencing Acute Ischemic Stroke (AIS). Additionally, ambulatory care centers is predicted to grow at fastest CAGR during the forecast period owing to its cost-effectiveness, productivity, increasing healthcare infrastructure, and surge in adoption of cutting-edge technologies.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing research & development activities, increasing prevalence of CVDs, rising number of clinical trial procedures for vascular access devices, and surge in launch of new products. For instance, in February 2023, Ra Medical Systems, Inc. has made an announcement regarding its wholly-owned subsidiary, Catheter Precision, Inc., which has initiated the launch of its LockeT product in the market. Initial shipments to distributors will commence promptly. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing geriatric population, rising prevalence of heart disorders, growing technological advancements, and surge in use of radial access devices. For instance, in April 2023, Surmodics, Inc., a prominent supplier of medical device and in vitro diagnostic technologies to the healthcare sector, has revealed that Dr. Ankur Lodha in Lafayette, Louisiana, and Dr. Pradeep Nair in Houma, Louisiana, are the inaugural physicians to employ the company's Sublime radial access microcatheter.
Segmentation: Transradial Access Market Report 2022 - 2033
Transradial Access Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Guidewires
- Accessories
- Catheters
- Sheaths & Sheath Introducers
Transradial Access Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Diagnostics & Testing
- Drug Administration
- Blood Transfusion
- Fluid & Nutrition Administration
Transradial Access Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Ambulatory Care Centers
- Hospitals & Clinics
- Others
Transradial Access Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Transradial Access Market: Product Estimates & Trend Analysis
8. Transradial Access Market: Application Estimates & Trend Analysis
9. Transradial Access Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Transradial Access Market
12. Europe Global Transradial Access Market
13. Asia Pacific Global Transradial Access Market
14. Latin America Global Transradial Access Market
15. MEA Global Transradial Access Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Boston Scientific Corporation
- Ameco Medical
- Merit Medical Systems
- Oscor Inc.
- Nipro Medical Corporation
- Teleflex Incorporated
- Terumo Corporation
- Medtronic
- Becton Dickinson
- Angiodynamics Inc.
- Smiths Medical
- Edward Lifesciences Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 2.36 Billion |
| Forecasted Market Value ( USD | $ 5.29 Billion |
| Compound Annual Growth Rate | 7.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
